Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Am Acad Dermatol. 2020 Apr 29;83(4):1130–1143. doi: 10.1016/j.jaad.2020.04.105

Figure 2.

Figure 2.

Bullous pemphigoid secondary to pembrolizumab. Biopsy shows perivascular eosinophils and vacuolar alteration along the junction. Bullae were not present histologically in the biopsy specimen. DIF showed deposition of C3 and IgG along the junction (not shown). Clinically, the patient had intact and eroded bullae on erythematous base.